Ketone Supplements and Substrate Oxidation and Physical Performance

Sponsor
United States Army Research Institute of Environmental Medicine (U.S. Fed)
Overall Status
Active, not recruiting
CT.gov ID
NCT04737694
Collaborator
(none)
15
1
2
22
0.7

Study Details

Study Description

Brief Summary

The objective of this randomized crossover study is to examine the influence of consuming a ketone ester plus carbohydrate (KE+CHO) supplement on substrate oxidation and physical performance in 15 healthy adults. Following a 48-hr muscle glycogen normalization period, volunteers will consume either an isocaloric KE+CHO (KE: 573 mg KE/kg body mass, CHO: 110 g) or isocaloric CHO drink and complete 90-min of metabolically-matched, load carriage (~30% body mass) steady-state aerobic (~60 ± 5 % of VO2peak) exercise on a treadmill. Glucose tracers will be used to assess glucose turnover, and contribution to exogenous and plasma glucose oxidation. Serial blood draws will be collected during each trial to assess endocrine and circulating substrate responses. After steady-state exercise volunteers will complete a time to exhaustion (TTE) physical performance tests at 85% VO2peak on a treadmill. Volunteers will then be provided with food for the remainder of the day. Following a 10-hr overnight fast, volunteers will return to the laboratory and consume the same supplement (KE+CHO or CHO) as they did the previous day. Volunteers will then perform a 4-mile load carriage time trial on a treadmill. Following a minimum 7-day washout period, volunteers will return to the laboratory to complete the second arm of the study. The primary risks associated with this study include those associated with exercise, blood draws, and gastrointestinal discomfort from the KE+CHO supplement.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Ketone ester
  • Dietary Supplement: Glucose
N/A

Detailed Description

Following an overnight (10 hour) fast, two catheters will be placed into the lower arm (one in each arm). One arm will be used for infusion of 6,6-[2H2] glucose tracer and the other will be used for blood sampling under resting and exercise conditions. Following an initial blood sample collection to determine background enrichments, a primed, continuous infusion of 6,6-[2H2] glucose will begin (prime, 82.2 µmol∙kg-1; continuous rate, 0.78 µmol∙kg-1∙min-1, Figure 1). The 6,6-[2H2] glucose will be infused for 100 min under resting fasted conditions to ensure isotopic steady-state is achieved prior to initiating exercise. Volunteers will consume either an isocaloric KE+CHO (KE: 573 mg KE/kg body mass, CHO: 110 g) or CHO drink prior to and during 90-min of metabolically-matched (~60 ± 5 % of VO2peak), steady-state load carriage (~30% body mass) exercise. Drinks will be enriched with U-13C-glucose (Cambridge Isotope Laboratory, Andover, MA, USA) to increase the isotopic enrichment well above natural levels and optimize the measurement of exogenous carbohydrate oxidation. During exercise V̇O2, V̇CO2, and HR will be measured at approximately 0, 20, 45, 60, 75, and 85 min.

After the 90-min steady-state treadmill exercise, participants will complete a TTE performance test. For volunteer safety TTE performance tests will be conducted without the additional weight from the load carriage exercise. Volunteers will be given time to stretch and warm-up on the treadmill before the TTE performance test beings. Volunteers will then run on the treadmill at a fixed speed and grade that elicits 85% of their VO2peak. The TTE performance test will be determined as the time of volitional exhaustion. Following completion of the test, a self-selected cool-down will occur. Volunteers will complete a minimum of two practice exercise sessions to ensure they are familiar with the performance test.

The following day volunteers will return to the laboratory after an overnight fast. After consuming the study drink (KE+CHO or CHO) participants will complete a self-paced 4-mile load carriage (~30% body mass) time trial on a treadmill to assess aerobic performance. Time trial performance will be assessed as the total amount of time taken to complete 4 miles. The treadmill will be set at a constant 1% grade for the entire test. Following a warm-up period, volunteers will blindly modulate treadmill speed in order to complete the distance as quickly as possible. The only feedback given will be distance covered at half mile increments. At half mile increments volunteers' rate of perceived exertion will be determined using the Borg Scale. Heart rate will be monitored throughout the time trial. Heart rate will be recorded at half mile increments. No motivation will be provided during the time trial. Participants may consume water ad libitum during the time trial. Following completion of the test, a self-selected cool-down will occur. Volunteers will complete a minimum of two practice exercise sessions to ensure they are familiar with the performance test.

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Double blinded randomized crossover designDouble blinded randomized crossover design
Masking:
Double (Participant, Investigator)
Masking Description:
Double blinded
Primary Purpose:
Other
Official Title:
Impact of Ketone Ester Supplementation on Substrate Oxidation and Physical Performance
Actual Study Start Date :
Nov 1, 2020
Actual Primary Completion Date :
Jun 1, 2021
Anticipated Study Completion Date :
Sep 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Ketone + Carbohydrate

573 mg/ kg body weight ketone ester + 110 g glucose

Dietary Supplement: Ketone ester
Oral ketone ester + glucose supplement

Active Comparator: Carbohydrate

Isocaloric amount of glucose to match ketone + carbohydrate

Dietary Supplement: Glucose
Glucose supplement

Outcome Measures

Primary Outcome Measures

  1. Time to exhaustion [30 minutes]

    Determine the effect of ketone esters plus carbohydrate (KE + CHO) supplementation on physical performance as determine by time to exhaustion at 85% VO2max on a treadmill compared to CHO alone

  2. Time trial [120 minutes]

    Determine the effect of ketone esters plus carbohydrate (KE + CHO) supplementation on physical performance as determine by a self paced 4 mile time trial on a treadmill compared to CHO alone

  3. Substrate oxidatoin [90 minutes]

    Determine the effect of KE + CHO supplementation on changes in substrate oxidation during moderate-intensity load carriage exercise compared to CHO alone.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 39 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Men and women aged 18 - 39 years

  • Body mass index (BMI) < 30 kg/m2

  • Routinely participate in aerobic and/or resistance exercise at least 2 days per week

  • Refrain from the use of caffeine, alcohol, dietary supplements, and nicotine while consuming study diets

  • Supervisor approval to participate for active duty military and federal civilian employees working within the US Army Natick Soldier Systems Center

Exclusion Criteria:
  • Metabolic or cardiovascular abnormalities, gastrointestinal disorders (i.e., kidney disease, diabetes, cardiovascular disease, etc.)

  • Disease or medication (i.e., diabetes medications, statins, corticosteroids, etc) that affects macronutrient utilization and/or the ability to participate in strenuous exercise

  • Allergies or intolerance to foods (including but not limited to lactose intolerance/milk allergy) to be utilized in the study or vegetarian practices

  • Present condition of alcoholism, anabolic steroids, or other substance abuse issues

  • Musculoskeletal injuries that compromise the ability to exercise

  • Not willing to avoid non-study exercise and foods during each of the 3 day testing periods

  • Blood donation within 8 weeks of beginning the study

  • Pregnant or breast feeding

Contacts and Locations

Locations

Site City State Country Postal Code
1 USARIEM Natick Massachusetts United States 01760

Sponsors and Collaborators

  • United States Army Research Institute of Environmental Medicine

Investigators

  • Principal Investigator: Lee M Margolis, PhD, United States Army Research Institute of Environmental Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
United States Army Research Institute of Environmental Medicine
ClinicalTrials.gov Identifier:
NCT04737694
Other Study ID Numbers:
  • 20-07HC
First Posted:
Feb 4, 2021
Last Update Posted:
Oct 14, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 14, 2021